The Biological Mechanism: Targeting Cell Death To understand the significance of this development, one must distinguish between the two primary…
Read More
KymaThera pulls in $80m to bring breast cancer drug to clinic – Pharmaceutical Technology
San Diego-based biopharmaceutical company KymaThera has successfully closed an $80 million Series B financing round to propel its lead oncology…
Read More
Eli Lilly Expands Multi-Million Dollar Biotech Partnership with Gate Bioscience to Pioneer ‘Molecular Gate’ Therapies for Hard-to-Drug Proteins
Eli Lilly and Company has significantly deepened its footprint in cutting-edge drug discovery by expanding its strategic partnership and licensing…
Read More
The biotech bi-weekly: an expansion into cardiac drug discovery, the world’s largest healthy human protein atlas and large libraries of AI-designed proteins
The global biotechnology sector continues to experience an unprecedented wave of innovation, marked by significant strides in laboratory reagents, cardiovascular…
Read More
Shionogi Expands Rare Disease Portfolio With $2 Billion Acquisition of IntraBio and Flagship Drug Aqneursa
Japanese pharmaceutical major Shionogi has announced a definitive agreement to acquire IntraBio in a multibillion-dollar transaction valued at $2 billion.…
Read More
The oral exposure challenge in PROTACs: What drug developers need to solve early
Proteolysis Targeting Chimera (PROTAC) technology has officially transitioned from a visionary academic concept to a cornerstone of modern clinical pharmacology.…
Read More
University of Toronto Engineers Develop Revolutionary Nanoparticles That Transform Infrared Light to Detect Trace Contaminants and Drug Impurities
In a breakthrough that bridges the gap between advanced nanotechnology and molecular detection, a team of chemical and materials engineers…
Read More
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
The American Association of Pharmaceutical Scientists (AAPS) has announced a significant evolution in the agenda for its 2026 PharmSci 360…
Read More
BioMarin Pharmaceutical and Profluent Partner to Accelerate AI-Driven Enzyme Therapies in Landmark Drug Discovery Collaboration
In a significant move bridging artificial intelligence and biotechnology, BioMarin Pharmaceutical has forged a strategic research collaboration with Emeryville-based tech…
Read More
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The landscape of modern pharmacology is currently undergoing a paradigm shift, one defined by a departure from the rigid structural…
Read More
